Form 4: Arteris Director Sells Shares via 10b5-1 Plan

Arteris Director Saiyed Atiq Raza sold 29,544 shares of common stock for approximately $10.07 per share through a pre-arranged 10b5-1 trading plan.

Summary

• Director Saiyed Atiq Raza of Arteris, Inc. (AIP) reported a sale of common stock.
• The transaction involved 29,544 shares of common stock.
• The shares were sold on July 29, 2025, at a weighted average price of $10.0658 per share, totaling approximately $297,260.00.
• The sale was executed under a Rule 10b5-1 trading plan adopted on June 6, 2024.
• Following the transaction, Saiyed Atiq Raza directly owns 20,839 shares and indirectly owns 653,118 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Sentiment

Score: 5

Explanation: The filing reports a pre-scheduled insider share sale, which is a neutral event as it does not necessarily reflect management's view on future performance but is a planned liquidity event.

Positives

• The share sale was conducted pursuant to a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which mitigates potential negative signaling.

Negatives

• A director sold a significant number of shares (29,544) of common stock, which reduces their direct equity stake in the company.

Risks

• Potential for negative investor sentiment due to insider share sales, even if pre-planned, as some investors may interpret it as a lack of confidence or a signal of perceived valuation.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it is a report of an insider transaction.

Industry Context

This filing reports an individual insider transaction and does not provide information related to broader industry trends or competitive landscape.

Related Party Transactions

• Indirect beneficial ownership of 653,118 shares is held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which the Reporting Person serves as trustee.

Stakeholder Impact

• Shareholders may interpret the insider sale differently; while mitigated by the 10b5-1 plan, some may still view it as a signal, potentially influencing short-term trading decisions.

Key Dates

Recommendation

The filing reports a pre-scheduled insider sale of shares, which is a routine liquidity event for the director and does not inherently signal a change in the company's fundamental outlook. Without additional information on company performance or strategic shifts, a 'hold' recommendation is appropriate as this transaction alone does not warrant a change in investment thesis.

Keywords

Arteris, AIP, Form 4, insider trading, share sale, director, 10b5-1 plan, beneficial ownership